Population-Based Health in Practice: Improving Gender-Informed Care Through an Understanding of Personal Pronouns

This activity is part of a series

Faculty

Rakesh Jain, MD, MPH
(he/him/his)
Clinical Professor, Department of Psychiatry
Texas Tech Health Sciences Center School of Medicine – Permian Basin
Midland, TX
Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH, is a Clinical Professor in the department of Psychiatry at the Texas Tech Health Sciences Center School of Medicine – Permian Basin in Midland, Texas and in private practice in Austin, Texas. Dr. Jain attended medical school at the University of Calcutta in India. He received his Master of Public Health (MPH) degree from the University of Texas School of Public Health in Houston, where he was awarded a National Institute/Center for Disease Control Competitive Traineeship. His research thesis focused on the impact of substance abuse.

Dr. Jain completed his residency in psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He then completed a postdoctoral fellowship in research psychiatry at the University of Texas Mental Sciences Institute in Houston. He was awarded the National Research Service Award in support of his postdoctoral fellowship.

Dr. Jain has been involved in over 100 research projects studying the effects of medications on short-term and long-term treatment of depression, anxiety, pain/mood overlap disorders, ADHD, and psychosis in adult and child/adolescent populations. He has presented at the World Psychiatric Congress held in Prague, and at Depression and Pain Forum meetings internationally. He is the author of 55 articles published in various journals and magazines, such as the Journal of Psychiatric Research and  Journal of Clinical Psychiatry, among others, and has presented over 25 original research posters at meetings such as the American Psychological Association (APA), the American College of Neuropsychopharmacology (ACNP), the American Academy of Child and Adolescent Psychiatry (AACAP), the U.S. Psychiatric Congress, and more. He has co-authored six books that range from patient education to cutting-edge neurobiologic findings in psychiatry and mental health. He serves on several advisory boards focusing on drug development and disease state education. He was also recently the Chair of the U.S. Psychiatric Congress, and for several years, has served as a member of the Steering Committee for U.S. Psychiatric Annual Congress. He is a recipient of the Public Citizen of the Year award from the National Association of Social Workers, Gulf Coast Chapter, in recognition of his community and peer education, and championing of mental health issues.

Diane M. Bruessow, MPAS, PA-C, DFAAPA
(she/her/hers)
Director of Justice, Equity, Diversity, and Inclusion, PA Online Program
Assistant Professor Adjunct, Department of Internal Medicine
Yale School of Medicine, New Haven, CT
Transhealth, Florence, MA
Healthy Transitions
Montclair, NJ
Diane M. Bruessow, MPAS, PA-C, DFAAPA

Diane Bruessow, PA-C, divides her time between practicing and teaching medicine. She is the Director of Justice, Equity, Diversity, and Inclusion and an Assistant Professor adjunct at the Yale School of Medicine PAO program, where she teaches the next generation of medical professionals about sexual and gender minority health. Her medical practice, Healthy Transitions, LLC, is dedicated to the care of transgender and nonbinary patients across the lifespan.

Tiffany A. Najberg, DO, FACEP
(she/her/hers)
CEO and Founder, Butterfly Medical Care
Shreveport, LA
Tiffany A. Najberg, DO, FACEP

Dr. Tiffany is a Board-Certified Emergency Physician who has served in busy emergency departments and provided prehospital care as well as remote care since 2007. A transwoman currently transitioning herself, she is the first open trans woman Emergency Physician in Louisiana. She is a business owner who owns her clinic, Butterfly Medical Care, in Shreveport, Louisiana. She practices acute care, primary care, LGBTQ care, and gender-affirming care there and via telehealth throughout the state. Her experience in remote medical direction led her to begin practicing transgender medicine via telemedicine, as making it accessible to all, even in isolated locations, is something she cares deeply about. She received her medical degree at the University of North Texas in Fort Worth and completed her emergency medicine residency at LSU New Orleans (Charity Hospital) and EMS fellowship with New Orleans EMS. She has been part of the teaching staff at Ochsner in New Orleans and St. Francis in Monroe and has a passion for medical education. She still actively instructs medical students at her clinic. Her non-medical interests include amateur storm chasing, writing, all things social, and she is a fierce advocate for public health, trans rights, women’s rights, and LGBTQ issues through her sizable online platforms.

Statement of Need

Transgender and non-binary individuals face overt discrimination and outright hostility in daily life, and the health care setting is not always a safe, welcoming place for these patients. This collective stigmatizing, invalidating, and traumatizing experience contributes to poor health outcomes for these individuals, including a disproportionate burden of depression, anxiety, and suicidal ideation and attempts. One low-effort, low-cost way to begin improving the care experience for transgender and non-binary patients is for clinicians and staff to ask for and use each patient’s preferred personal pronouns. This modest effort, when accompanied by empathetic communication and behavior, can begin to improve the experience for transgender and non-binary individuals and can encourage them to seek care proactively.

This educational presentation features health care experts who will share actionable strategies for incorporating the use of personal pronouns into clinical practice to foster a safe and inclusive care environment.

Learning Objectives

  • Identify the significance of personal pronouns in clinical practice, particularly in the care of patients who identify as transgender and/or non-binary
  • Implement actionable strategies incorporating the use of personal pronouns in clinical care to foster a safe, inclusive health care environment

Financial Support

This program is supported by an independent medical education grant from CVS Health.

Target Audience

Physicians, nurse practitioners (NPs), nurses, physician associates (PAs), pharmacists, and pharmacy technicians within the CVS Health System

Credit Information

Jointly accredited provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.75

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education Credit for learning and change.

Physicians (ACCME) 0.75

CME Outfitters, LLC, designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hours.

Pharmacists (ACPE) 0.75

This application-based activity is approved for 0.75 contact hours ( 0.075 CEUs) of continuing pharmacy credit ( JA0007185-0000-23-129-H01-P ).

Pharmacists/Pharmacy Tech (ACPE) 0.75

This application-based activity is approved for 0.75 contact hours ( 0.075 CEUs) of continuing pharmacy credit ( JA0007185-0000-23-129-H01-T ).

PAs (AAPA) 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 08/30/2025. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 0.75

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

Dr. Jain reports the following financial relationships:

Advisory Board: Adamas Pharmaceuticals, Inc.; Alkermes; Corium, Inc.; Eisai Inc.; Janssen Pharmaceuticals, Inc.; Lilly; Lundbeck; Merck & Co., Inc.; Neos Therapeutics, Inc.; Neurocrine Biosciences, Inc.; Otsuka America Pharmaceutical, Inc.; Pamlab; Pfizer Inc.; Sage Therapeutics, Inc.; Shire Pharmaceuticals; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; Teva Pharmaceuticals USA, Inc.; and Usona Institute

Consultant: AbbVie Inc. (Allergan); Acadia Pharmaceuticals Inc.; Adamas Pharmaceuticals, Inc.; Alfasigma USA, Inc.; Axsome Therapeutics, Inc.; Biogen; Boehringer Ingleheim; Corium, Inc.; Cingulate; Eisai Inc.; Evidera; Impel Pharmaceuticals Inc.; Janssen Pharmaceuticals, Inc.; Lilly; Lundbeck; Merck & Co., Inc.; Neos Therapeutics, Inc.; Neurocrine Biosciences, Inc.; Osmotica Pharmaceuticals; Otsuka America Pharmaceutical, Inc.; Pamlab; Pfizer Inc.; Sage Therapeutics, Inc; Shire Pharmaceuticals; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; Teva Pharmaceuticals USA, Inc.; and Transcend Therapeutics

Research Support: AbbVie Inc. (Allergan); Lilly; Lundbeck; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Shire Pharmaceuticals; and Takeda Pharmaceuticals U.S.A., Inc.

Speakers Bureau: AbbVie Inc. (Allergan); Alkermes; Axsome Therapeutics, Inc.; Corium, Inc.; Eisai Inc.; Indivior; Intra-Cellular Therapies, Inc.; Ironshore Pharmaceuticals Inc.; Janssen Pharmaceuticals, Inc.; Lilly; Lundbeck; Merck & Co., Inc.; Neos Therapeutics, Inc.; Neurocrine Biosciences, Inc.; Otsuka America Pharmaceutical, Inc.; Pamlab; Pfizer Inc.; Shire Pharmaceuticals; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals U.S.A., Inc.; Teva Pharmaceuticals USA, Inc.; and Tris Pharma, Inc.

Dr. Najberg reports no financial relationships to disclose.

Ms. Bruessow reports no financial relationships to disclose.

 

The following individuals have no financial relationships to disclose:

Joshua Caballero, PharmD, BCPP, FCCP (Peer Reviewer)
Jeffrey Helfand, DO (Peer Reviewer)
Morgan Stockberger, MD (Planning Committee)
Jessica Whelan, DNP, APRN, FPMHNP-BC, RN-BC (Planning Committee)
Susan H. Yarbrough, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

SN-228-121323-80

Population-Based Health in Practice: Improving Gender-Informed Care Through an Understanding of Personal Pronouns
Event Date: 12/13/2023